• 1. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 2. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Anilides

2-(Tert-Butylcarbonylamino)-6-Chlorophenylboronic Acid (CAS No. 1451390-83-2): A Versatile Compound in Modern Medicinal Chemistry

2-(Tert-Butylcarbonylamino)-6-chlorophenylboronic acid (CAS No. 1451390-83-2) is a versatile compound that has gained significant attention in the field of medicinal chemistry due to its unique structural features and potential applications in drug discovery and development. This compound, characterized by its boronic acid functionality and a tert-butylcarbonylamino substituent, offers a range of opportunities for synthetic chemists and pharmaceutical researchers.

The tert-butylcarbonylamino group in 2-(Tert-Butylcarbonylamino)-6-chlorophenylboronic acid provides enhanced stability and reactivity, making it an attractive building block for the synthesis of complex molecules. The presence of the chloro substituent on the phenyl ring further enhances its reactivity and selectivity in various chemical reactions, particularly in cross-coupling reactions and bioconjugation processes.

Recent studies have highlighted the importance of boronic acids in medicinal chemistry, particularly in the development of targeted therapies. The boronic acid functionality in 2-(Tert-Butylcarbonylamino)-6-chlorophenylboronic acid can be utilized to form stable complexes with metal ions, which can be crucial for the design of metal-based drugs and imaging agents. Additionally, the boronic acid group can participate in reversible binding interactions with biological targets, such as carbohydrates and proteins, making it a valuable tool in the development of diagnostic agents and therapeutic molecules.

In the context of drug discovery, 2-(Tert-Butylcarbonylamino)-6-chlorophenylboronic acid has shown promise as a scaffold for the development of small molecule inhibitors. For instance, a study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibited potent inhibitory activity against specific kinases involved in cancer progression. The ability to fine-tune the properties of these derivatives through structural modifications has opened new avenues for the design of more selective and effective therapeutic agents.

Moreover, 2-(Tert-Butylcarbonylamino)-6-chlorophenylboronic acid has been explored for its potential use in bioconjugation reactions. The boronic acid group can form covalent bonds with hydroxyl groups on biomolecules, such as sugars and amino acids, enabling the creation of targeted drug delivery systems. This property has been leveraged in the development of prodrugs that are activated upon reaching specific cellular environments, thereby enhancing their therapeutic efficacy while minimizing side effects.

The synthetic accessibility of 2-(Tert-Butylcarbonylamino)-6-chlorophenylboronic acid is another factor contributing to its popularity among researchers. Various synthetic routes have been developed to efficiently produce this compound, including palladium-catalyzed cross-coupling reactions and multistep synthesis strategies. These methods allow for high yields and purity, ensuring that the compound can be readily incorporated into complex molecular architectures.

In addition to its applications in drug discovery and bioconjugation, 2-(Tert-Butylcarbonylamino)-6-chlorophenylboronic acid has also been investigated for its potential use in materials science. The unique electronic properties of boronic acids make them suitable for applications in organic electronics and photovoltaic devices. Recent research has shown that derivatives of this compound can be used to create functional materials with tunable optical and electronic properties, opening new possibilities for advanced technological applications.

The versatility of 2-(Tert-Butylcarbonylamino)-6-chlorophenylboronic acid extends beyond its chemical properties. Its ability to form stable complexes with metal ions has led to its use in catalysis, where it can serve as a ligand for transition metal catalysts. This application is particularly relevant in the field of homogeneous catalysis, where efficient and selective catalysts are essential for industrial processes.

In conclusion, 2-(Tert-Butylcarbonylamino)-6-chlorophenylboronic acid (CAS No. 1451390-83-2) is a multifaceted compound with a wide range of applications in medicinal chemistry, bioconjugation, materials science, and catalysis. Its unique structural features and reactivity profile make it an invaluable tool for researchers seeking to develop innovative solutions in these fields. As ongoing research continues to uncover new possibilities, this compound is likely to play an increasingly important role in advancing scientific knowledge and technological innovation.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)